BioNexus Gene Lab Corp. Gain (Loss) on Investments
BioNexus Gene Lab Corp. (BGLC) reported Gain (Loss) on Investments of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-06.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2022-04-06
- BioNexus Gene Lab Corp. gain (loss) on investments for the quarter ending 2020-12-31 was -$5.98K.
- BioNexus Gene Lab Corp. gain (loss) on investments for the quarter ending 2020-09-30 was $58.00.
- BioNexus Gene Lab Corp. gain (loss) on investments for the quarter ending 2019-12-31 was $0.00.
- BioNexus Gene Lab Corp. gain (loss) on investments for the quarter ending 2019-09-30 was $0.00.
- BioNexus Gene Lab Corp. gain (loss) on investments for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BioNexus Gene Lab Corp. gain (loss) on investments for fiscal 2020 was $3.96K.
- BioNexus Gene Lab Corp. gain (loss) on investments for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-04-06 | |||
| 2020-12-31 | -$5.98K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-04-06 | -$5.92K derived: sum of 2 quarters · filed 2022-04-06 | $3.96K 10-K · filed 2022-04-06 | |
| 2020-09-30 | $58.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $9.95K 10-Q/A · filed 2020-11-09 | ||
| 2020-06-30 | $9.89K 10-Q · filed 2020-08-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q/A · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |